A candidate dual vaccine against influenza and noroviruses
- 13 October 2011
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 29 (44), 7670-7677
- https://doi.org/10.1016/j.vaccine.2011.07.139
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Health
- National Institute of Allergy and Infectious Diseases (R01 AI37093, R01 AI055649, R01 AI089634)
- Department of Defense (PR033018)
- Institutional Clinical and Translational Science (1UL1RR026314-01)
This publication has 33 references indexed in Scilit:
- Norovirus–host interaction: Multi-selections by human histo-blood group antigensTrends in Microbiology, 2011
- Norovirus P Particle, a Novel Platform for Vaccine Development and Antibody ProductionJournal of Virology, 2011
- Genetic and Phenotypic Characterization of GII-4 Noroviruses That Circulated during 1987 to 2008Journal of Virology, 2010
- Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A virusesProceedings of the National Academy of Sciences of the United States of America, 2010
- An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza virusesVirology Journal, 2010
- Noroviral P particle: Structure, function and applications in virus–host interactionVirology, 2008
- Elucidation of strain-specific interaction of a GII-4 norovirus with HBGA receptors by site-directed mutagenesis studyVirology, 2008
- An Influenza A Vaccine Based on Tetrameric Ectodomain of Matrix Protein 2Published by Elsevier BV ,2008
- C-Terminal Arginine Cluster Is Essential for Receptor Binding of Norovirus Capsid ProteinJournal of Virology, 2006
- Influenza-Associated Hospitalizations in the United StatesJama-Journal Of The American Medical Association, 2004